View Future GrowthTessenderlo Group 과거 순이익 실적과거 기준 점검 0/6Tessenderlo Group 의 수입은 연평균 -34.6%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 4.4%의 비율로 감소했습니다. 매출은 연평균 8.4%의 비율로 증가해 왔습니다.핵심 정보-34.64%순이익 성장률-38.57%주당순이익(EPS) 성장률Chemicals 산업 성장률12.41%매출 성장률8.36%자기자본이익률-4.70%순이익률-2.94%다음 순이익 업데이트27 Aug 2026최근 과거 실적 업데이트공시 • Mar 04+ 1 more updateTessenderlo Group NV to Report First Half, 2026 Results on Aug 27, 2026Tessenderlo Group NV announced that they will report first half, 2026 results on Aug 27, 2026공시 • Mar 26Tessenderlo Group NV to Report First Half, 2025 Results on Aug 21, 2025Tessenderlo Group NV announced that they will report first half, 2025 results on Aug 21, 2025Reported Earnings • Aug 25First half 2024 earnings released: EPS: €0.97 (vs €1.27 in 1H 2023)First half 2024 results: EPS: €0.97 (down from €1.27 in 1H 2023). Revenue: €1.39b (down 15% from 1H 2023). Net income: €60.4m (down 25% from 1H 2023). Profit margin: 4.3% (down from 4.9% in 1H 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.공시 • Aug 21Tessenderlo Group NV to Report Fiscal Year 2024 Results on Mar 26, 2025Tessenderlo Group NV announced that they will report fiscal year 2024 results on Mar 26, 2025Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.74 (vs €5.27 in FY 2022)Full year 2023 results: EPS: €1.74 (down from €5.27 in FY 2022). Revenue: €2.93b (up 13% from FY 2022). Net income: €109.5m (down 52% from FY 2022). Profit margin: 3.7% (down from 8.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.공시 • Jan 09Tessenderlo Group NV to Report First Half, 2024 Results on Aug 21, 2024Tessenderlo Group NV announced that they will report first half, 2024 results on Aug 21, 2024모든 업데이트 보기Recent updatesBoard Change • May 21High number of new directorsIndependent Non-Executive Director Beatrice Bruey was the last director to join the board, commencing their role in 2026.공시 • Mar 04+ 1 more updateTessenderlo Group NV to Report First Half, 2026 Results on Aug 27, 2026Tessenderlo Group NV announced that they will report first half, 2026 results on Aug 27, 2026공시 • May 22Tessenderlo Group NV announces Annual dividend, payable on June 06, 2025Tessenderlo Group NV announced Annual dividend of EUR 0.5250 per share payable on June 06, 2025, ex-date on June 04, 2025 and record date on June 05, 2025.공시 • Mar 27Tessenderlo Group NV, Annual General Meeting, May 13, 2025Tessenderlo Group NV, Annual General Meeting, May 13, 2025.공시 • Mar 26Tessenderlo Group NV to Report First Half, 2025 Results on Aug 21, 2025Tessenderlo Group NV announced that they will report first half, 2025 results on Aug 21, 2025Reported Earnings • Aug 25First half 2024 earnings released: EPS: €0.97 (vs €1.27 in 1H 2023)First half 2024 results: EPS: €0.97 (down from €1.27 in 1H 2023). Revenue: €1.39b (down 15% from 1H 2023). Net income: €60.4m (down 25% from 1H 2023). Profit margin: 4.3% (down from 4.9% in 1H 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.공시 • Aug 21Tessenderlo Group NV to Report Fiscal Year 2024 Results on Mar 26, 2025Tessenderlo Group NV announced that they will report fiscal year 2024 results on Mar 26, 2025Board Change • Apr 11Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Non-Executive Director Ann Vereecke was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.74 (vs €5.27 in FY 2022)Full year 2023 results: EPS: €1.74 (down from €5.27 in FY 2022). Revenue: €2.93b (up 13% from FY 2022). Net income: €109.5m (down 52% from FY 2022). Profit margin: 3.7% (down from 8.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.New Risk • Mar 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.0% net profit margin).공시 • Jan 09Tessenderlo Group NV to Report First Half, 2024 Results on Aug 21, 2024Tessenderlo Group NV announced that they will report first half, 2024 results on Aug 21, 2024Reported Earnings • Aug 25First half 2023 earnings released: EPS: €1.27 (vs €3.80 in 1H 2022)First half 2023 results: EPS: €1.27 (down from €3.80 in 1H 2022). Revenue: €1.63b (up 21% from 1H 2022). Net income: €80.4m (down 51% from 1H 2022). Profit margin: 4.9% (down from 12% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.공시 • Aug 24+ 1 more updateTessenderlo Group NV, Annual General Meeting, May 14, 2024Tessenderlo Group NV, Annual General Meeting, May 14, 2024.Upcoming Dividend • May 24Upcoming dividend of €0.53 per share at 2.5% yieldEligible shareholders must have bought the stock before 31 May 2023. Payment date: 02 June 2023. Trailing yield: 2.5%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.6%).Reported Earnings • Mar 24Full year 2022 earnings released: EPS: €5.26 (vs €4.37 in FY 2021)Full year 2022 results: EPS: €5.26 (up from €4.37 in FY 2021). Revenue: €2.59b (up 24% from FY 2021). Net income: €226.9m (up 21% from FY 2021). Profit margin: 8.8% (down from 9.0% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.공시 • Dec 20Tessenderlo Group NV to Report First Half, 2023 Results on Aug 24, 2023Tessenderlo Group NV announced that they will report first half, 2023 results on Aug 24, 2023공시 • Oct 27Tessenderlo Group NV to Report Fiscal Year 2022 Results on Mar 23, 2023Tessenderlo Group NV announced that they will report fiscal year 2022 results on Mar 23, 2023Reported Earnings • Aug 26First half 2022 earnings released: EPS: €3.80 (vs €2.26 in 1H 2021)First half 2022 results: EPS: €3.80 (up from €2.26 in 1H 2021). Revenue: €1.34b (up 31% from 1H 2021). Net income: €163.6m (up 68% from 1H 2021). Profit margin: 12% (up from 9.5% in 1H 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 13% compared to a 2.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 27Full year 2020 earnings released: EPS €2.30 (vs €2.23 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: €1.74b (flat on FY 2019). Net income: €99.1m (up 3.1% from FY 2019). Profit margin: 5.7% (up from 5.5% in FY 2019). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Mar 03New 90-day high: €37.10The company is up 12% from its price of €33.10 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €138 per share.Is New 90 Day High Low • Jan 22New 90-day high: €37.00The company is up 23% from its price of €30.00 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €138 per share.Is New 90 Day High Low • Jan 06New 90-day high: €33.95The company is up 6.0% from its price of €32.15 on 08 October 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €137 per share.Is New 90 Day High Low • Dec 21New 90-day high: €33.90The company is up 4.0% from its price of €32.75 on 22 September 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €136 per share.매출 및 비용 세부 내역Tessenderlo Group가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:TEZ 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 252,763-81422030 Sep 252,755-54426030 Jun 252,746-27430031 Mar 252,6978425031 Dec 242,64843420030 Sep 242,66966416030 Jun 242,69190412031 Mar 242,810100409031 Dec 232,928110407030 Sep 232,901127399030 Jun 232,874144390031 Mar 232,731185370031 Dec 222,588227349030 Sep 222,494241341030 Jun 222,400254332031 Mar 222,241221319031 Dec 212,082188307030 Sep 211,952149293030 Jun 211,823110280031 Mar 211,780105278031 Dec 201,73799277030 Sep 201,745118278030 Jun 201,753136280031 Mar 201,748116282031 Dec 191,74396284030 Sep 191,72290281030 Jun 191,70183279031 Mar 191,66187275031 Dec 181,62192272030 Sep 181,59977272030 Jun 181,57863272031 Mar 181,61844275031 Dec 171,65726278030 Sep 171,65851273030 Jun 171,66076268031 Mar 171,62587262031 Dec 161,59099257030 Sep 161,59291260030 Jun 161,59484263031 Mar 161,59284263031 Dec 151,58985263030 Sep 151,53965260030 Jun 151,509702530양질의 수익: TEZ 은(는) 현재 수익성이 없습니다.이익 마진 증가: TEZ는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: TEZ은 수익성이 없으며 지난 5년 동안 손실이 연평균 34.6% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 TEZ의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: TEZ은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-13.5%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: TEZ는 현재 수익성이 없으므로 자본 수익률이 음수(-4.7%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 07:19종가2026/05/21 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Tessenderlo Group NV는 5명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Mark GevensBNP ParibasFrank ClaassenDegroof PetercamOliver ReiffDeutsche Bank2명의 분석가 더 보기
공시 • Mar 04+ 1 more updateTessenderlo Group NV to Report First Half, 2026 Results on Aug 27, 2026Tessenderlo Group NV announced that they will report first half, 2026 results on Aug 27, 2026
공시 • Mar 26Tessenderlo Group NV to Report First Half, 2025 Results on Aug 21, 2025Tessenderlo Group NV announced that they will report first half, 2025 results on Aug 21, 2025
Reported Earnings • Aug 25First half 2024 earnings released: EPS: €0.97 (vs €1.27 in 1H 2023)First half 2024 results: EPS: €0.97 (down from €1.27 in 1H 2023). Revenue: €1.39b (down 15% from 1H 2023). Net income: €60.4m (down 25% from 1H 2023). Profit margin: 4.3% (down from 4.9% in 1H 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
공시 • Aug 21Tessenderlo Group NV to Report Fiscal Year 2024 Results on Mar 26, 2025Tessenderlo Group NV announced that they will report fiscal year 2024 results on Mar 26, 2025
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.74 (vs €5.27 in FY 2022)Full year 2023 results: EPS: €1.74 (down from €5.27 in FY 2022). Revenue: €2.93b (up 13% from FY 2022). Net income: €109.5m (down 52% from FY 2022). Profit margin: 3.7% (down from 8.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
공시 • Jan 09Tessenderlo Group NV to Report First Half, 2024 Results on Aug 21, 2024Tessenderlo Group NV announced that they will report first half, 2024 results on Aug 21, 2024
Board Change • May 21High number of new directorsIndependent Non-Executive Director Beatrice Bruey was the last director to join the board, commencing their role in 2026.
공시 • Mar 04+ 1 more updateTessenderlo Group NV to Report First Half, 2026 Results on Aug 27, 2026Tessenderlo Group NV announced that they will report first half, 2026 results on Aug 27, 2026
공시 • May 22Tessenderlo Group NV announces Annual dividend, payable on June 06, 2025Tessenderlo Group NV announced Annual dividend of EUR 0.5250 per share payable on June 06, 2025, ex-date on June 04, 2025 and record date on June 05, 2025.
공시 • Mar 27Tessenderlo Group NV, Annual General Meeting, May 13, 2025Tessenderlo Group NV, Annual General Meeting, May 13, 2025.
공시 • Mar 26Tessenderlo Group NV to Report First Half, 2025 Results on Aug 21, 2025Tessenderlo Group NV announced that they will report first half, 2025 results on Aug 21, 2025
Reported Earnings • Aug 25First half 2024 earnings released: EPS: €0.97 (vs €1.27 in 1H 2023)First half 2024 results: EPS: €0.97 (down from €1.27 in 1H 2023). Revenue: €1.39b (down 15% from 1H 2023). Net income: €60.4m (down 25% from 1H 2023). Profit margin: 4.3% (down from 4.9% in 1H 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
공시 • Aug 21Tessenderlo Group NV to Report Fiscal Year 2024 Results on Mar 26, 2025Tessenderlo Group NV announced that they will report fiscal year 2024 results on Mar 26, 2025
Board Change • Apr 11Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Non-Executive Director Ann Vereecke was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.74 (vs €5.27 in FY 2022)Full year 2023 results: EPS: €1.74 (down from €5.27 in FY 2022). Revenue: €2.93b (up 13% from FY 2022). Net income: €109.5m (down 52% from FY 2022). Profit margin: 3.7% (down from 8.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
New Risk • Mar 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.0% net profit margin).
공시 • Jan 09Tessenderlo Group NV to Report First Half, 2024 Results on Aug 21, 2024Tessenderlo Group NV announced that they will report first half, 2024 results on Aug 21, 2024
Reported Earnings • Aug 25First half 2023 earnings released: EPS: €1.27 (vs €3.80 in 1H 2022)First half 2023 results: EPS: €1.27 (down from €3.80 in 1H 2022). Revenue: €1.63b (up 21% from 1H 2022). Net income: €80.4m (down 51% from 1H 2022). Profit margin: 4.9% (down from 12% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
공시 • Aug 24+ 1 more updateTessenderlo Group NV, Annual General Meeting, May 14, 2024Tessenderlo Group NV, Annual General Meeting, May 14, 2024.
Upcoming Dividend • May 24Upcoming dividend of €0.53 per share at 2.5% yieldEligible shareholders must have bought the stock before 31 May 2023. Payment date: 02 June 2023. Trailing yield: 2.5%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.6%).
Reported Earnings • Mar 24Full year 2022 earnings released: EPS: €5.26 (vs €4.37 in FY 2021)Full year 2022 results: EPS: €5.26 (up from €4.37 in FY 2021). Revenue: €2.59b (up 24% from FY 2021). Net income: €226.9m (up 21% from FY 2021). Profit margin: 8.8% (down from 9.0% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
공시 • Dec 20Tessenderlo Group NV to Report First Half, 2023 Results on Aug 24, 2023Tessenderlo Group NV announced that they will report first half, 2023 results on Aug 24, 2023
공시 • Oct 27Tessenderlo Group NV to Report Fiscal Year 2022 Results on Mar 23, 2023Tessenderlo Group NV announced that they will report fiscal year 2022 results on Mar 23, 2023
Reported Earnings • Aug 26First half 2022 earnings released: EPS: €3.80 (vs €2.26 in 1H 2021)First half 2022 results: EPS: €3.80 (up from €2.26 in 1H 2021). Revenue: €1.34b (up 31% from 1H 2021). Net income: €163.6m (up 68% from 1H 2021). Profit margin: 12% (up from 9.5% in 1H 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 13% compared to a 2.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 27Full year 2020 earnings released: EPS €2.30 (vs €2.23 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: €1.74b (flat on FY 2019). Net income: €99.1m (up 3.1% from FY 2019). Profit margin: 5.7% (up from 5.5% in FY 2019). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Mar 03New 90-day high: €37.10The company is up 12% from its price of €33.10 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €138 per share.
Is New 90 Day High Low • Jan 22New 90-day high: €37.00The company is up 23% from its price of €30.00 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €138 per share.
Is New 90 Day High Low • Jan 06New 90-day high: €33.95The company is up 6.0% from its price of €32.15 on 08 October 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €137 per share.
Is New 90 Day High Low • Dec 21New 90-day high: €33.90The company is up 4.0% from its price of €32.75 on 22 September 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €136 per share.